Vuity vs Tyrvaya
A side-by-side look at two eye health medications advertised on TV. Informational only — not medical advice.
| US Vuity | US Tyrvaya | |
|---|---|---|
| Generic name | pilocarpine ophthalmic | varenicline nasal spray |
| Drug class | Cholinergic Muscarinic Agonist (Eye Drop) | Nicotinic Acetylcholine Receptor Agonist (Nasal) |
| Treats | Age-related blurry near vision (presbyopia) | Dry eye disease |
| Category | Eye Health | Eye Health |
| Manufacturer | AbbVie (Allergan) | Viatris |
| Year approved | 2021 | 2021 |
| FDA warning | No boxed warning | No boxed warning |
| Est. TV ad spend | $70M | — |
| Common side effects | Headache, Eye redness, Trouble with night vision, Eye pain | Sneezing, Cough, Throat irritation, Nose irritation |
Frequently asked questions
Is Vuity or Tyrvaya better?
Neither is universally "better." Vuity (pilocarpine ophthalmic) and Tyrvaya (varenicline nasal spray) are both used for eye health, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Vuity and Tyrvaya?
Vuity is a Cholinergic Muscarinic Agonist (Eye Drop) made by AbbVie (Allergan), while Tyrvaya is a Nicotinic Acetylcholine Receptor Agonist (Nasal) made by Viatris. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Vuity has the larger estimated TV advertising budget of the two.